The Research and Development Team at Cytokinetics is dedicated to advancing the discovery and development of innovative muscle activators aimed at treating conditions related to impaired muscle function. Comprising a diverse group of scientific advisors, senior researchers, and directors, the team collaborates on preclinical and clinical research efforts, focusing on drug discovery, safety, and patient engagement to bring effective therapies to market. Their work is pivotal in translating scientific insights into viable treatment options for patients in need.
Andrew A. Wolff
SVP, Senior Fellow, Clinical R...
Anne N. Murphy
VP, Biology
Bradley P. Morgan
SVP, Research and Non-Clinical...
Brian M. Stoltz
Scientific Advisor
David Morgans
Scientific Advisor
Fady I. Malik
EVP, Research and Development
John Lowe
Scientific Advisor
John Solaro
Scientific Advisor
Paul A. Wender
Scientific Advisor
Roger A. Fielding
Scientific Advisor
View all